Zainab Lafi

574 total citations
32 papers, 370 citations indexed

About

Zainab Lafi is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Zainab Lafi has authored 32 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Biomaterials and 6 papers in Pharmaceutical Science. Recurrent topics in Zainab Lafi's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (6 papers) and Advanced Drug Delivery Systems (5 papers). Zainab Lafi is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (6 papers) and Advanced Drug Delivery Systems (5 papers). Zainab Lafi collaborates with scholars based in Jordan, United States and United Arab Emirates. Zainab Lafi's co-authors include Walhan Alshaer, Hamdi Nsairat, Dana A. Alqudah, Abdalla Awidi, Malek Zihlif, Lobna Gharaibeh, Yasser Bustanji, Mohammed El‐Khateeb, Kamel Ajlouni and Yacoub M. Irshaid and has published in prestigious journals such as PLoS ONE, Food Chemistry and Molecules.

In The Last Decade

Zainab Lafi

27 papers receiving 366 citations

Peers

Zainab Lafi
Zainab Lafi
Citations per year, relative to Zainab Lafi Zainab Lafi (= 1×) peers Ritu Karwasra

Countries citing papers authored by Zainab Lafi

Since Specialization
Citations

This map shows the geographic impact of Zainab Lafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zainab Lafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zainab Lafi more than expected).

Fields of papers citing papers by Zainab Lafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zainab Lafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zainab Lafi. The network helps show where Zainab Lafi may publish in the future.

Co-authorship network of co-authors of Zainab Lafi

This figure shows the co-authorship network connecting the top 25 collaborators of Zainab Lafi. A scholar is included among the top collaborators of Zainab Lafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zainab Lafi. Zainab Lafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lafi, Zainab, et al.. (2025). Co-encapsulation of coumarin and Q10 into solid lipid nanoparticles for wound healing. Journal of Drug Delivery Science and Technology. 105. 106645–106645. 5 indexed citations
2.
Gharaibeh, Lobna, et al.. (2025). Exploring fracture risk assessment tool (FRAX®) for women 50 years and older: A cross-sectional study. Electronic Journal of General Medicine. 22(2). em633–em633.
3.
Rifai, A, Dana A. Alqudah, Hamdi Nsairat, et al.. (2025). Quality by digital design for accelerated sustainable nanomedicine development. European Journal of Pharmaceutical Sciences. 213. 107239–107239. 3 indexed citations
4.
Lafi, Zainab, et al.. (2025). A Recent Review of PLGA-PEG Hybrid Nanoparticles for Anticancer and Anti-Inflammatory Applications. Jordan Journal of Pharmaceutical Sciences. 18(1). 180–195. 2 indexed citations
5.
Alshaer, Walhan, Zainab Lafi, Hamdi Nsairat, et al.. (2025). Remote Co-Loading of Doxorubicin and Hydralazine into PEGylated Liposomes: In Vitro Anti-Proliferative Effect Against Breast Cancer. Molecules. 30(7). 1549–1549. 1 indexed citations
6.
Lafi, Zainab, et al.. (2025). Formation and evaluation of doxorubicin and cromoglycate metal–organic framework for anti-cancer activity. Nanomedicine. 20(5). 467–479. 5 indexed citations
7.
Gharaibeh, Lobna, et al.. (2025). Practices and knowledge of community pharmacists towards the use of proton pump inhibitors: a cross-sectional study in Jordan. BMJ Open. 15(2). e085589–e085589. 1 indexed citations
8.
Lafi, Zainab, et al.. (2025). CRISPR in clinical diagnostics: bridging the gap between research and practice. Bioanalysis. 17(4). 281–290. 4 indexed citations
9.
Nsairat, Hamdi, Zainab Lafi, Belal O. Al‐Najjar, et al.. (2025). How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery? A Comprehensive Review of the Literature. International Journal of Nanomedicine. Volume 20. 2133–2161. 10 indexed citations
10.
Lafi, Zainab, et al.. (2024). Hyaluronic Acid in Nanopharmaceuticals: An Overview. Current Issues in Molecular Biology. 46(9). 10444–10461. 17 indexed citations
11.
Lafi, Zainab, et al.. (2024). Metal–organic frameworks as nanoplatforms for combination therapy in cancer treatment. Medical Oncology. 42(1). 26–26. 7 indexed citations
12.
Lafi, Zainab, et al.. (2024). Analytical Approaches for Assessing Curcumin and Nicotinamide Co-Encapsulated in Liposomal Formulation: UV Spectrophotometry and HPLC Validation. Jordan Journal of Pharmaceutical Sciences. 17(3). 468–480. 5 indexed citations
13.
Lafi, Zainab, et al.. (2024). Anticancer activity of liposomal formulation co-encapsulated with coumarin and phenyl butyric acid. Journal of Applied Pharmaceutical Science. 6 indexed citations
14.
Nsairat, Hamdi, et al.. (2023). Impact of nanotechnology on the oral delivery of phyto-bioactive compounds. Food Chemistry. 424. 136438–136438. 31 indexed citations
15.
Lafi, Zainab, et al.. (2023). Echinomycin: A Journey of Challenges. Jordan Journal of Pharmaceutical Sciences. 16(3). 640–654. 8 indexed citations
16.
Lafi, Zainab, et al.. (2023). Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line. PLoS ONE. 18(9). e0291981–e0291981. 15 indexed citations
17.
Alshaer, Walhan, et al.. (2022). Multifunctional nanoparticles recruiting hyaluronic acid ligand and polyplexes containing low molecular weight protamine and ATP-Sensitive DNA motif for doxorubicin delivery. Journal of Drug Delivery Science and Technology. 69. 103169–103169. 9 indexed citations
18.
Lafi, Zainab, et al.. (2022). Ethnopharmacological importance of local flora in the traditional medicine of Jordan: (A mini review). Jordan Journal of Pharmaceutical Sciences. 15(1). 132–144. 16 indexed citations
19.
Alshaer, Walhan, Amer Amer, Hamdi Nsairat, et al.. (2019). Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: in vitro anti-proliferative and anti-invasive activity in glioblastoma. RSC Advances. 9(53). 30976–30988. 56 indexed citations
20.
Lafi, Zainab, Yacoub M. Irshaid, Mohammed El‐Khateeb, Kamel Ajlouni, & Dana Hyassat. (2015). Association of rs7041 and rs4588 Polymorphisms of the Vitamin D Binding Protein and the rs10741657 Polymorphism of CYP2R1 with Vitamin D Status Among Jordanian Patients. Genetic Testing and Molecular Biomarkers. 19(11). 629–636. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026